Idexx Laboratories Inc. diskutieren
Idexx Laboratories Inc.
WKN: 888210 / Symbol: IDXX / Name: IDEXX Labs / Aktie / Ausrüstung & Versorgung / Large Cap /
461,60 €
-0,85 %
Sell Idexx Laboratories Inc.
Buy Idexx Laboratories Inc.
T-Shirt printing design online : United Graphic offers the best custom t shirts Online.We can design custom logo t shirts for you. Free Shipping, Place the order online.
Sell Idexx Laboratories Inc.
Sell Idexx Laboratories Inc.
IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target raised by analysts at Morgan Stanley from $543.00 to $590.00. They now have an "overweight" rating on the stock.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories, Inc. (NASDAQ: IDXX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target raised by analysts at Morgan Stanley from $590.00 to $600.00. They now have an "overweight" rating on the stock.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $578.00 to $500.00. They now have a "buy" rating on the stock.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target raised by analysts at Piper Sandler from $520.00 to $525.00. They now have an "overweight" rating on the stock.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories, Inc. (NASDAQ: IDXX) is now covered by analysts at BNP Paribas. They set an "outperform" rating and a $602.00 price target on the stock.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories, Inc. (NASDAQ: IDXX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $500.00 to $650.00. They now have a "buy" rating on the stock.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target raised by analysts at Barclays PLC from $605.00 to $655.00. They now have an "overweight" rating on the stock.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target raised by analysts at JPMorgan Chase & Co. from $600.00 to $630.00. They now have an "overweight" rating on the stock.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target lowered by analysts at Barclays PLC from $655.00 to $570.00. They now have an "overweight" rating on the stock.
Ratings data for IDXX provided by MarketBeat
IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target lowered by analysts at Morgan Stanley from $620.00 to $596.00. They now have an "overweight" rating on the stock.
Ratings data for IDXX provided by MarketBeat
Neueste Beiträge
William_Blair in nCino Inc. diskutieren